retatrutide needles has become the first obesity drug to report 30.3% average weight loss. But that headline needs context. The result came from a 104-week extension involving participants who began with a BMI general Concentration:20mg Fella Health and Semaglutide:

retatrutide needles has become the first obesity drug to report 30.3% average weight loss. But that headline needs context. The result came from a 104-week extension involving participants who began with a BMI general Concentration:20mg Fella Health and Semaglutide:

Fella Health and Semaglutide: Model and Pathway | PlexusDx

Medical literature indicates that slowed gastric emptying from GLP-1 therapy might actually benefit some post-surgical patients by allowing more time for bile and pancreatic enzymes to mix with food

general

Concentration:20mg

Patients should be counseled that scale weight may not accurately reflect body composition changes